STING1 and neoplasm: To further verify whether the tumor cells were dying, we specifically labeled a CD45– tumor cell subset using flow cytometry (Supplemental Figure 4F) and found that STING-NP and iBINP treatments notably increased T cell–triggered killing of tumor cells, as shown by propidium iodide+ staining (Figure 4K).